SN
TARO

Sittner & Nelson’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Sittner & Nelson’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-100
Closed -$7K – 416
2021
Q1 		$7K Hold
100
– – 0.01% 321
2020
Q4 		$7K Buy
+100
New +$6.43K 0.01% 307

Other funds holding TARO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sittner & Nelson's TARO Position: Q2 2021 in Review

Sittner & Nelson sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q2 2021, closing a stake of 100 shares — an estimated $7K sold.

Sittner & Nelson first reported a position in TARO in Q4 2020 and held it in 2 quarters. The position peaked at $7K in Q1 2021. 76 funds tracked by Wall St. Rank hold TARO as of Q2 2021.

  • Sittner & Nelson reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q2 2021 after selling out during the quarter.
  • Sittner & Nelson sold 100 Taro Pharmaceutical Industries Ltd. shares in Q2 2021, an estimated $7K.
  • Sittner & Nelson first reported a position in Taro Pharmaceutical Industries Ltd. in Q4 2020 and held it in 2 quarters.
  • Sittner & Nelson's Taro Pharmaceutical Industries Ltd. position peaked at $7K in Q1 2021.
  • 76 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q2 2021.

Based on Sittner & Nelson's 13F filing for Q2 2021, filed 12 Aug 2021.